Neosem Inc. (KOSDAQ:253590)

Elevation Oncology Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	356,992	371,442	309,085	122,244	126,008	125,833
Market Cap Growth	-31.46%	20.18%	152.84%	-2.99%	0.14%	165.81%
Enterprise Value	295,289	323,754	285,173	103,156	119,764	115,948
Last Close Price	8400.00	8740.00	7797.02	3328.36	3543.84	3524.05
PE Ratio	20.54	19.33	37.32	12.23	22.33	15.58
Forward PE	-	6.03	6.03	12.05	-	-
PS Ratio	3.89	3.53	3.06	1.64	3.39	2.59
PB Ratio	3.10	3.21	3.56	1.96	2.47	2.91
P/TBV Ratio	3.43	3.54	4.01	2.33	3.03	3.62
P/FCF Ratio	23.56	24.54	61.27	12.10	-	9.22
P/OCF Ratio	18.40	19.25	29.23	9.21	-	9.09
EV/Sales Ratio	3.22	3.08	2.83	1.38	3.22	2.38
EV/EBITDA Ratio	17.13	17.78	29.83	10.54	20.30	8.82
EV/EBIT Ratio	19.18	19.66	35.27	12.33	24.70	9.65
EV/FCF Ratio	19.48	21.39	56.53	10.21	-	8.49
Debt / Equity Ratio	0.04	0.04	0.06	0.37	0.60	0.32
Debt / EBITDA Ratio	0.23	0.28	0.56	2.38	5.14	1.05
Debt / FCF Ratio	0.27	0.34	1.06	2.31	-	1.01
Asset Turnover	0.72	0.85	0.85	0.68	0.49	0.76
Inventory Turnover	3.99	4.26	2.16	1.75	3.32	4.38
Quick Ratio	4.31	3.71	3.14	0.77	5.35	2.76
Current Ratio	5.20	4.44	4.30	1.54	6.03	3.17
Return on Equity (ROE)	16.18%	18.96%	11.11%	17.66%	11.99%	20.01%
Return on Assets (ROA)	7.60%	8.29%	4.26%	4.76%	3.97%	11.71%
Return on Capital (ROIC)	8.49%	9.65%	5.69%	6.27%	4.38%	13.08%
Return on Capital Employed (ROCE)	13.00%	13.80%	9.00%	12.70%	6.10%	23.40%
Earnings Yield	4.88%	5.17%	2.68%	8.18%	4.48%	6.42%
FCF Yield	4.25%	4.08%	1.63%	8.27%	-5.67%	10.85%
Dividend Yield	0.72%	0.69%	0.39%	1.05%	-	-
Payout Ratio	14.64%	6.45%	15.35%	5.45%	12.84%	4.55%
Buyback Yield / Dilution	-1.50%	-1.76%	-14.02%	13.96%	-16.50%	-4.74%
Total Shareholder Return	-0.78%	-1.07%	-13.63%	15.01%	-16.50%	-4.74%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.